Study of the Safety and Efficacy of APX3330 in Diabetic Retinopathy

Clinical trial NCT04692688 · COMPLETED

Trial details

NCT number: NCT04692688
Sponsor: Ocuphire Pharma, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetic Retinopathy Diabetic Macular Edema NPDR - Non Proliferative Diabetic Retinopathy PDR - Proliferative Diabetic Retinopathy

Start date: 2021-04-08
Primary completion: 2023-01-25
Enrollment: 103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.